Resources

Most patients with Type 2 diabetes are not receiving care as per the ADA guidelines released in 2004 for diabetic nephropathy.

A landmark study conducted by the National Institutes of Health (NIH) found that those at risk for type-II diabetes could reduce the likelihood of developing the disease by 58 percent through 30 minutes of moderate daily exercise.

The oral anti-diabetic thiazolidinediones (TZDs), such as rosiglitazone and pioglitazone could offer a valuable complement to conventional chemotherapy for pancreatic cancer.

People with type 2 diabetes who have progressed to kidney failure don’t gain much benefit from treatment with a statin drug like Lipitor.

Percentage of low-income Asian and Pacific Islander children in California who are overweight more than doubled between 1994 and 2003, from 7 percent to 15 percent.

The Transdermal Insulin Drug Delivery (TDD) System Dermisonics’ research has centered upon the creation of a unique hardware platform, to make a wearable, lightweight drug delivery system possible. The Transdermal Drug Delivery (TDD) System employs a flexible patch design integral to the new two-part TDD called the Medi-Cap. The Sonic …

We all have patients that end up in Chemotherapy for different Cancers. Did you know some of the newest and best cancer fighting drugs have a side effect of chemotherapy-induced neuropathy. A. Lee Dellon, MD shows that the same treatments for diabetic neuropathy will work for these patients.

A gene involved in the action of insulin is associated with type 2 diabetes and the body’s response to insulin has been found and reported on.

Rosiglitazone improves pancreatic β-cell response after six months as reflected by measures of insulin sensitivity and first-phase insulin response.

Americans are getting a little taller and a lot fatter.